Atlas Trials

Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride

Clinical trial NCT00424762 · COMPLETED

Trial details

NCT number
NCT00424762
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2005-02-01
Primary completion
2007-04-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.